IXC 1.35% 7.5¢ invex therapeutics ltd

Ann: Postcard to Shareholders, page-28

  1. 8,545 Posts.
    lightbulb Created with Sketch. 1403
    What's the point of being bought out after a successful P3 when the drug is about to be approved anyway? By then you may as well market it youself, or licence it and keep overall control.

    An earlier buyout would be a different matter.

    Holding a decent parcel.
    Last edited by IndexInvestor: 19/03/21
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.